Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies: Success Of Clinical Trial On Prediction Of Remission In Patients With Inflammatory Bowel Disease

Oct 31 (Reuters) - Mauna Kea Technologies SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES ANNOUNCES SUCCESS OF CLINICAL TRIAL
ON
PREDICTION OF REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL
DISEASE (IBD) AND ITS PUBLICATION IN GASTROENTEROLOGY

Source text for Eikon:  ID:nBwzlMQTa 
Further company coverage:  MKEA.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Mauna Kea Technologies SA

See all news